New treatments in Noninfectious Uveitis. E. Miserocchi, G. Modorati, C. S. Foster. Developments in Ophthalmology Vol. 51

[Developments in Ophthalmology] New Trea

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || Rituximab for Noninfectious Uveitis

✍ Miserocchi, E.; Modorati, G.; Foster, C.S. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 153 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || The Gold Standard of Noninfectious Uveitis: Corticosteroids

✍ Miserocchi, E.; Modorati, G.; Foster, C.S. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 543 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || Corticosteroid Intravitreal Implants

✍ Miserocchi, E.; Modorati, G.; Foster, C.S. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 299 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || Anti-Tumor Necrosis Factor-a Agents in Noninfectious Uveitis

✍ Miserocchi, E.; Modorati, G.; Foster, C.S. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 313 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || New Biologic Drugs: Anti-Interleukin Therapy

✍ Miserocchi, E.; Modorati, G.; Foster, C.S. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 355 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao

[Developments in Ophthalmology] New Trea

[Developments in Ophthalmology] New Treatments in Noninfectious Uveitis Volume 51 || The Philosophy of Treatment of Uveitis: Past, Present and Future

✍ Miserocchi, E.; Modorati, G.; Foster, C.S. 📂 Article 📅 2012 🏛 S. KARGER AG 🌐 English ⚖ 90 KB

Uveitis is a potentially blinding inflammatory disease that presents one of the most serious and complicated therapeutic challenges in the field of ophthalmology. During the last decade, the therapeutic armamentarium of the uveitis specialist has enormously expanded. Novel biologic agents and intrao